Effect of aspirin and celecoxib on Helicobacter pylori in vitro

World Chinese Journal of Digestology

Volumn 14, Issue 28, 2006, Pages 2747-2752

  Ma, Hui Xia ^a   Wang, Wei Hong ^a   Hu, Fu Lian ^a   Li, Jiang ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Aspirin; Celecoxib; Helicobacter pylori; Non steroidal anti inflammatory drug

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; OUTER MEMBRANE PROTEIN; UREASE; VACUOLATING TOXIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BRUCELLA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HELA CELL; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; SPECTROPHOTOMETRY;

EID: 33845674599     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Romano M, Ricci V, Memoli A, Tuccillo C, Di Popolo A, Sommi P, Acquaviva AM, Del Vecchio Blanco C, Bruni CB, Zarrilli R. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro. J Biol Chem 1998; 273: 28560-28563
2. Kim JM, Kim JS, Jung HC, Song IS, Kim CY. Upregulated cyclooxygenase-2 inhibits apoptosis of human gastric epithelial cells infected with Helicobacter pylori. Dig Dis Sci 2000; 45: 2436-2443
3. Bhang CS, Lee HS, Kim SS, Song HJ, Sung YJ, Kim JI, Chung IS, Sun HS, Park DH, Lee YS. Effects of selective cyclooxygenase-2 inhibitor and non-selective NSAIDs on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2002; 7: 14-21
4. Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22
5. Schaeverbeke T, Broutet N, Zerbib F, Combe B, Bertin P, Lamouliatte H, Perie F, Joubert-Collin M, Megraud F. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study. Am J Gastroenterol 2005; 100: 2637-2643
6. Gu Q, Xia HH, Wang WH, Wang JD, Wong WM, Chan AO, Yuen MF, Lam SK, Cheung HK, Liu XG, Wong BC. Effect of cyclo-oxygenase inhibitors on Helicobacter pylori susceptibility to metronidazole and clarithromycin. Aliment Pharmacol Ther 2004; 20: 675-681
7. Wang WH, Wong WM, Dailidiene D, Berg DE, Gu Q, Lai KC, Lam SK, Wong BC. Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 2003; 52: 490-495
8. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994; 264: 382-388
9. Putman M, van Veen HW, Konings WN. Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev 2000; 64: 672-693
10. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-610
11. Cover TL, Cao P, Murthy UK, Sipple MS, Blaser MJ. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992; 90: 913-918
12. Doig P, Trust TJ. Identification of surface-exposed outer membrane antigens of Helicobacter pylori. Infect Immun 1994; 62: 4526-4533
13. Grigoriadou S, Quraishi A, Saravanna J, Saravanan V, Heycock C, Kelly C. What effect does Helicobacter pylori infection have on the risk of peptic ulceration in patients receiving NSAIDs for rheumatoid arthritis? Eur J Intern Med 2002; 13: 269-273
14. Papatheodoridis GV, Papadelli D, Cholongitas E, Vassilopoulos D, Mentis A, Hadziyannis SJ. Effect of helicobacter pylori infection on the risk of upper gastrointestinal bleeding in users of nonsteroidal anti-inflammatory drugs. Am J Med 2004; 116: 601-605
15. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, Yeomans ND. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998; 338: 727-734
16. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, Swannell AJ, Hawkey CJ. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med 1998; 338: 719-726
17. Vergara M, Catalan M, Gisbert JP, Calvet X. Metaanalysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther 2005; 21: 1411-1418
18. Wang WH, Hu FL, WONG BCY, BERG DE, LAM SK. Inhibitory effects of aspirin and indometacin on the growth of Helicobacter pylori in vitro. Chinese J Dig Dis 2002; 3: 172-177
19. Shirin H, Moss SF, Kancherla S, Kancherla K, Holt PR, Weinstein IB, Sordillo EM. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori. J Gastroenterol Hepatol 2006; 21: 1388-1393
20. Windsor HM, O'Rourke J. Bacteriology and taxonomy of Helicobacter pylori. Gastroenterol Clin North Am 2000; 29: 633-648
21. Hazell SL, Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion, and gastric ulcers. Lancet 1986; 2: 15-17
22. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994; 89: S116-128
23. Tee W, Lambert JR, Dwyer B. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J Clin Microbiol 1995; 33: 1203-1205
24. Qiao W, Hu JL, Xiao B, Wu KC, Peng DR, Atherton JC, Xue H. cagA and vacA genotype of Helicobacter pylori associated with gastric diseases in Xi'an area. World J Gastroenterol 2003; 9: 1762-1766
25. Hocker M, Hohenberger P. Helicobacter pylori virulence factors-one part of a big picture. Lancet 2003; 362: 1231-1233
26. Park SH, Park DI, Kim SH, Kim HJ, Cho YK, Sung IK, Sohn CI, Jeon WK, Kim BI, Keum DK. Effect of high-dose aspirin on Helicobacter pylori eradication. Dig Dis Sci 2005; 50: 626-629
27. Doig P, Exner MM, Hancock RE, Trust TJ. Isolation and characterization of a conserved porin protein from Helicobacter pylori. J Bacteriol 1995; 177: 5447-5452
28. Exner MM, Doig P, Trust TJ, Hancock RE. Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect Immun 1995; 63: 1567-1572
29. Kwon DH, Dore MP, Kim JJ, Kato M, Lee M, Wu JY, Graham DY. High-level beta-lactam resistance associated with acquired multidrug resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003; 47: 2169-2178